Allena Pharmaceuticals, Inc. Alternatives & Competitors

12 companies similar to Allena Pharmaceuticals, Inc. — Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney D...

Novome Biotechnologies

Engineering Living Medicines for Chronic Diseases

1 Series B $82.84M

South San Francisco, Unit...

Biopharma Biotechnology +1

Jupiter Neurosciences, Inc.

A clinical-stage drug platform company focused on treating neuroinflammation.

6 Private Equity

Jupiter, United States

Biotechnology Pharmaceutical

Rezolute, Inc.

Rezolute is developing transformative therapeutics for rare and metabolic diseases.

66 Post-IPO Equity $356.00M

Redwood City, United Stat...

Biotechnology Health Care +1

X4 Pharmaceuticals

Enabling a better future for people with rare immune disorders

137 Post-IPO Debt $520.31M

Boston, United States

Biotechnology Health Care +2

Track all Allena Pharmaceuticals, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cara Therapeutics

Transforming the way pruritus is treated to bring quality to the lives of those who suffer

46 Post-IPO Debt $517.20M

Stamford, United States

Biotechnology Health Care +1

Alzprotect SAS

Therapeutic Solutions for Neurodegeneration

12 Grant $16.34M

Loos, France

Biotechnology Pharmaceutical

Spero Therapeutics

Clinical-stage biotech company focused on rare diseases and diseases with high unmet need

44 IPO $374.60M

Cambridge, United States

Biotechnology Pharmaceutical

Soleno Therapeutics, Inc.

Inspired by patients and families around the world, we are advancing much needed therapies...

88 Post-IPO Equity $319.20M

Redwood City, United Stat...

Biotechnology Pharmaceutical

Atorvia Health Technologies

Fearlessly tackling kidney failure

5 Grant $28.00K

Kanata, Canada

Biotechnology Health Care +2

Navitor Pharmaceuticals

10 Venture round $98.17M

Cambridge, United States

Biopharma Biotechnology +3

Pharvaris

Pioneering science for patient choice

168 IPO $967.33M

Zug, Switzerland

Biotechnology Health Care +2

Zevra Therapeutics

A Rare Approach to Therapeutics

71 Post-IPO Debt $213.75M

Celebration, United State...

Biotechnology Health and Wellness +1

About Allena Pharmaceuticals, Inc.

Allena Pharmaceuticals, Inc. is a biotechnology and pharmaceutical startup that focuses on developing therapeutics for patients suffering from rare and severe metabolic and kidney disorders. Founded in 2011 and headquartered in the United States, the company's mission is to address metabolic disorders leading to the ex...

Taxonomy

Biopharmaceutical Company, Oral Enzyme Therapeutics, Metabolic Disorders, Kidney Disorders, Rare Diseases, Renal Disease, Clinical Trials, Enzyme Technology, GI Tract, Oxalate Reduction, Urate Reduction, Chronic Kidney Disease, Phase 3 Clinical Program, Enteric Hyperoxaluria, Drug Development

Frequently Asked Questions

Companies similar to Allena Pharmaceuticals, Inc. include Novome Biotechnologies, Jupiter Neurosciences, Inc., Rezolute, Inc., X4 Pharmaceuticals, Cara Therapeutics. They work in Biotechnology and Pharmaceutical and share Allena Pharmaceuticals, Inc.'s focus on drug development, biopharmaceutical company and rare diseases.

Bounce Watch lists 12 companies that share Allena Pharmaceuticals, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Allena Pharmaceuticals, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Allena Pharmaceuticals, Inc. Profile Novome Biotechnologies Alternatives Jupiter Neurosciences, Inc. Alternatives Rezolute, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Allena Pharmaceuticals, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.